Shauneen Beukes – Page 2 – Aspen Pharmacare

Stephen Saad, Aspen Chief Executive address to President Ramaphosa and his delegation at Aspen’s flagship manufacturing site in Gqberha, Eastern Cape

By Shauneen Beukes | Mar 29, 2021 |

“Our Aspen philosophy has always been to give purpose to life. This is best achieved by contributing meaningfully to others. Aspen has defined itself and continues to define itself as a company that serves humanity, particularly the most vulnerable amongst us. It was over a decade ago that we made a special announcement on a…

Aspen increases revenue by 17% to R18.6 billion

By Shauneen Beukes | Mar 11, 2021 |

Johannesburg – JSE Limited listed Aspen Pharmacare Holdings Limited (APN), a global multinational specialty pharmaceutical company, has announced unaudited interim financial results for the six months ended 30 December 2021. Stephen Saad, Aspen Group Chief Executive said, “The business has delivered pleasing results and has proven to be in robust shape over the past six…

Modern Slavery Statement

By Shauneen Beukes | Dec 10, 2020 |

Aspen Group statement on Modern Slavery Preamble Increasingly international legislation and protocol require companies to act in respect of modern slavery. Specifically, the UK Modern Slavery Act and the Australian Modern Slavery Act require companies to disclose their efforts to address the risk of modern slavery in their businesses. This statement provides insight into Aspen’s…

J&J Vaccine News Coverage

By Shauneen Beukes | Nov 17, 2020 |

Aspen concludes strategic partnership with US-based Avion Pharmaceuticals

By Shauneen Beukes | Nov 12, 2020 |

Durban – United States-based Aspen Pharma USA Inc. and Aspen Global Incorporated, located in Mauritius, both wholly owned subsidiaries of Aspen Pharmacare Holdings Limited, have announced a license and commercialisation agreement with Avion Pharmaceuticals, LLC, a specialty pharmaceutical company, for the exclusive rights to relaunch Cenestin® in the USA. This is a New Drug Application…

Aspen announces agreement with Johnson & Johnson to manufacture investigational COVID-19 vaccine candidate

By Shauneen Beukes | Nov 2, 2020 |

Durban, South Africa – Aspen is pleased to announce that one of its wholly-owned South African subsidiaries, Pharmacare Limited (which trades as “Aspen Pharmacare”), has entered into a preliminary agreement with Janssen Pharmaceuticals, Inc., and Janssen Pharmaceutica NV, two of the Janssen Pharmaceutical Companies of Johnson & Johnson, for the technical transfer and proposed commercial…

Aspen increases revenue by 9% to R38,6 billion

By Shauneen Beukes | Sep 9, 2020 |

Johannesburg – JSE Limited listed Aspen Pharmacare Holdings Limited (APN), a global multinational specialty pharmaceutical company, has announced reviewed provisional Group financial results for the year ended 30 June 2020. COMMENTARY RESHAPING OF THE GROUP The recently announced agreement to divest the assets related to the commercialisation of Aspen’s Thrombosis business in Europe to Mylan…

Divestment of Aspen’s European Thrombosis Business to Mylan and withdrawal of cautionary

By Shauneen Beukes | Sep 8, 2020 |

Johannesburg – Following the release of a cautionary announcement on 24 August 2020, Aspen is pleased to announce that, Aspen Global Incorporated (“AGI”), its wholly owned subsidiary incorporated in Mauritius, has concluded an agreement in terms of which Mylan Ireland Limited (“Mylan”) will acquire the commercialisation rights and related intellectual property relating to Aspen’s Thrombosis…

Ethicare donates 3 000 face shields to pharmacists

By Shauneen Beukes | Jul 23, 2020 |

An Ethicare initiative The unprecedented arrival of COVID-19 in South Africa forced everyone to come to terms with a new normal. The grave reality of the pandemic was highlighted with the announcement of a national lockdown on 23 March 2020. This drastic measure was implemented to flatten the curve and slow the spread of the…

Aspen scoops prized Adam Smith Treasury Award

By Shauneen Beukes | Jul 22, 2020 |

Aspen’s Group Treasury Team was recently recognised when they were awarded the highly acclaimed Adam Smith 2020 Best In Class Treasury Solution In Africa Award.

Aspen celebrates a decade of participation in Mandela Day

By Shauneen Beukes | Jul 17, 2020 |

Johannesburg – JSE Limited listed Aspen Pharmacare Holdings Limited (APN), a global multinational specialty pharmaceutical company, is celebrating its 10th year of participation in the annual Mandela International Day (Mandela Day) campaign. Stephen Saad, Aspen Group Chief Executive said, “We participated in our first initiative in 2011 when we partnered with the Rekopane Inclusive Development…

Aspen debuts in the FTSE4Good Index Series

By Shauneen Beukes | Jul 9, 2020 |

The annual FTSE Russell Environmental, Social and Governance (ESG) Ratings have been published and Aspen has been included as a constituent member in the global FTSE4Good Index Series for the first time. Jeanette Englund Aspen Group Risk Sustainability Manager said, “We are delighted to be included in the global FTSE4Good Index Series for the first…